Skip to main navigation Skip to search Skip to main content

Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis

  • Chih Wei Hsu*
  • , Andre F. Carvalho
  • , Shang Ying Tsai
  • , Liang Jen Wang
  • , Ping Tao Tseng
  • , Pao Yen Lin
  • , Yu Kang Tu
  • , Eduard Vieta
  • , Marco Solmi
  • , Chi Fa Hung
  • , Hung Yu Kao
  • *Corresponding author for this work
  • Deakin University
  • Taipei Medical University
  • Prospect Clinic for Otorhinolaryngology & Neurology
  • National Sun Yat-sen University
  • Asia University Taiwan
  • Chang Gung University
  • Chang Gung Memorial Hospital
  • National Taiwan University
  • University of Barcelona
  • University of Padua
  • National Cheng Kung University

Research output: Contribution to journal › Journal Article › peer-review

28 Scopus citations

Abstract

Objective: To compare differences in efficacy during maintenance treatment for bipolar disorder (BD) according to lithium serum levels. A multicenter retrospective cohort study and a dose-response meta-analysis were conducted. Methods: The cohort study was conducted in Taiwan from 2001 to 2019 to identify patients with euthymic BD according to different serum levels (<0.4, 0.4–0.8, and 0.8–1.2 mmol/L). We adopted adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) for time to the recurrence of mood episodes having the <0.4 mmol/L group as the reference group. Moreover, we systematically searched for related articles in major databases before January 31, 2021 (PROSPERO: CRD42021235812). We used random-effects modeling to estimate the dose-response relationships between lithium serum levels and recurrence of mood episodes, which were depicted as odds ratios (ORs) with 95% CIs. Results: A total of 1406 participants (cohort: 466; meta-analysis: 940) were included. In the cohort study, the 0.4–0.8 mmol/L group was associated with a significantly lower risk of recurrences (aHR: 0.75), while the 0.8–1.2 mmol/L group had a lower risk without statistical significance (aHR: 0.77). The dose-response meta-analysis showed that with the increase in lithium serum levels, the risk decreased (linear model OR: 0.85, for every 0.1 mmol/L increase; non-linear model OR: 1.00 at 0.0 mmol/L, 0.42 at 0.4 mmol/L, and 0.27 at 0.8 mmol/L). Conclusion: Although confounding by indication cannot be excluded, the combined results suggest a significant preventative effect on the recurrence of major affective episodes among those with serum levels of 0.4–0.8 mmol/L.

Original languageEnglish
Pages (from-to)368-378
Number of pages11
JournalActa Psychiatrica Scandinavica
Volume144
Issue number4
DOIs
StatePublished - 10 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.

Keywords

  • bipolar disorder
  • dose-response meta-analysis
  • lithium
  • maintenance treatment
  • serum level

Fingerprint

Dive into the research topics of 'Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis'. Together they form a unique fingerprint.

Cite this